Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SER150 in Diabetic Kidney Disease
NCT04881123Phase 3Completed
- Sponsor
- Serodus
- Start
- Aug 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of EV-077 in diabetic kidney disease (DKD), sponsored by Serodus. Started Aug 2021; status: completed.
02
Drugs
EV-077
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT04881123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04881123.